Copyright Nasdaq. Minimum 15 minutes delayed.
Summary ToggleIntellia Therapeutics Announces WT1 as Its First Cell Therapy Target, Following Presentation of Early Data at the American Society of Gene and Cell Therapy 21st Annual Meeting
Jun 5, 20183:00 PM EDT
Intellia Therapeutics, Inc. at the Jefferies Global Health Care Conference